Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding DE:OM3E?
Track your performance easily
DE:OM3E Price & Analysis
OM3E ETF Chart & Stats
Day’s Range― - ―
52-Week Range€5.01 - €6.77
Previous Close€6.36
VolumeN/A
Average Volume (3M)1.00K
AUM34.81M
NAV6.58
Expense Ratio0.35%
Holdings Count213
Beta0.36
Inception DateMar 06, 2018
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. VolumeN/A
30 Day Avg. Volume1,002
AlphaN/A
iShares NASDAQ US Biotechnology UCITS ETF (OM3E) Fund Flow Chart
iShares NASDAQ US Biotechnology UCITS ETF (OM3E) 1 year Net Flows: -€8M
OM3E ETF News
PremiumMarket News
SPY ETF Update, 11/22/2024 OM3E ETF FAQ
What was DE:OM3E’s price range in the past 12 months?
DE:OM3E lowest ETF price was €5.01 and its highest was €6.77 in the past 12 months.
What is the AUM of DE:OM3E?
As of Nov 22, 2024 The AUM of DE:OM3E is 34.81M.
Is DE:OM3E overvalued?
According to Wall Street analysts DE:OM3E’s price is currently Undervalued.
Does DE:OM3E pay dividends?
DE:OM3E does not currently pay dividends.
How many shares outstanding does DE:OM3E have?
Currently, no data Available
Which hedge fund is a major shareholder of DE:OM3E?
Currently, no hedge funds are holding shares in DE:OM3E
OM3E ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Gilead Sciences
9.95%
Vertex Pharmaceuticals Inc.
7.95%
Amgen Inc
7.60%
Regeneron Pharmaceuticals
5.50%
AstraZeneca
3.97%
Alnylam Pharmaceuticals
3.36%
Biogen Inc.
2.44%
Illumina
2.32%
Argenx
2.03%
United Therapeutics Corp.
1.73%
Total46.86%
ETF Description
iShares NASDAQ US Biotechnology UCITS ETF
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the NASDAQ Biotechnology Index.